Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis

Molecular Pharmaceutics

Volumn 6, Issue 5, 2009, Pages 1363-1370

  Cavaletti, Guido ^a   Cassetti, Arianna ^a,e   Canta, Annalisa ^a   Galbiati, Stefania ^a,f   Gilardini, Alessandra ^a   Oggioni, Norberto ^a   Rodriguez Menendez, Virginia ^a   Fasano, Anna ^b   Liuzzi, Grazia Maria ^b   Fattler, Ursula ^c   Ries, Stefan ^c,g   Nieland, John ^c,h   Riccio, Paolo ^d   Haas, Heinrich ^c  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c MediGene AG   (Germany)

^d UNIVERSITY OF BASILICATA   (Italy)

^e CRA Experimental Institute for Floriculture   (Italy)

^f Ospedale Versilia (LU)   (Italy)

^g ROCHE DIAGNOSTICS GMBH   (Germany)

^h Metabolistic ApS   (Denmark)

Author keywords

Angiogenesis; Blood brain barrier, BBB; Cancer; Cationic liposomes; Drug delivery; Experimental autoimmune encephalomyelitis, EAE; Inflammation; Multiple sclerosis, MS

Indexed keywords

ANIONIC LIPOSOME; CATIONIC LIPOSOME; ENDOTAG 1; LIPOSOME; PACLITAXEL; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BINDING AFFINITY; BLOOD BRAIN BARRIER; COLLOID; CONFERENCE PAPER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; DRUG DISTRIBUTION; DRUG PENETRATION; FEMALE; INFLAMMATION; MULTIPLE SCLEROSIS; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SPINAL CORD;

ANIMALS; BLOOD-BRAIN BARRIER; DRUG CARRIERS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; LIPOSOMES; MICROSCOPY, CONFOCAL; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, INBRED LEW; SPINAL CORD; STATIC ELECTRICITY;

EID: 68049091042     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp8001478     Document Type: Conference Paper

References (45)

1. Lucchinetti, C.; Bruck, W.; Parisi, J.; Scheithauer, B.; Rodriguez, M.; Lassmann, H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 2000, 47 (6), 707-717 (Pubitemid 30390191)
2. Bruck, W.; Stadelmann, C. The spectrum of multiple sclerosis: new lessons from pathology. Curr. Opin. Neurol. 2005, 18 (3), 221-224 (Pubitemid 40813746)
3. Harris, J. O.; Frank, J. A.; Patronas, N.; McFarlin, D. E.; McFarland, H. F. Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann. Neurol. 1991, 29 (5), 548-555
4. Werring, D. J.; Brassat, D.; Droogan, A. G.; Clark, C. A.; Symms, M. R.; Barker, G. J.; MacManus, D. G.; Thompson, A. J.; Miller, D. H. The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: A serial diffusion MRI study. Brain 2000, 123 (8), 1667-1676. (Pubitemid 30481190)
5. Riccio, P.; Haas, H.; Liuzzi, G. M.; Rossano, R. New diagnostic and therapeutic options for the treatment of multiple sclerosis. In Clinical Applications for Immunomics. Immunomics Rev. vol.2; Falus A., Ed.; Springer Verlag: Heidelberg, 2008; pp 205-226
6. Haas, H.; Riccio, P. Cationic colloidal carriers for delivery of active agents to the blood-brain barrier in the course of neuroinflammatory diseases; WO2008052766, 2007.
7. Thurston, G.; McLean, J. W.; Rizen, M.; Baluk, P.; Haskell, A.; Murphy, T. J.; Hanahan, D.; McDonald, D. M. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J. Clin. Invest. 1998, 101 (7), 1401-1413
8. Campbell, R. B.; Gohongi, T.; Torchilin, V. P.; Fukumura, D.; Jain, R. K. Effect of charge on vascular targeting of tumors to cationic liposomes: an intravital microscopic study in mice. Proc. Int. Symp Controlled Release Bioact. Mater. 2000, 27.
9. Krasnici, S.; Werner, A.; Eichhorn, M. E.; Schmitt-Sody, M.; Pahernik, S. A.; Sauer, B.; Schulze, B.; Teifel, M.; Michaelis, U.; Naujoks, K.; Dellian, M. Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels. Int. J. Cancer 2003, 105 (4), 561-567 (Pubitemid 36578564)
10. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1995, 1 (1), 27-31.
11. Iozzo, R. V. Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J. Clin. Invest. 2001, 108 (2), 165-167
12. Augustin, H. G.; Kozian, D. H.; Johnson, R. C. Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes. Bioessays 1994, 16 (12), 901-906 (Pubitemid 24974469)
13. Ran, S.; Thorpe, P. E. Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy. Int. J. Radiat. Oncol. Biol. Phys. 2002, 54 (5), 1479-1484
14. Ran, S.; Downes, A.; Thorpe, P. E. Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res. 2002, 62 (21), 6132-6140
15. Kirkpatrick, A. P.; Kaiser, T. A.; Shepherd, R. D.; Rinker, K. D. In Biochemical mediated glycocalyx modulation in human umbilical Vein endothelial cells (HUVEC), Summer Bioengineering Conference, Florida, 2003.
16. Lonez, C.; Vandenbranden, M.; Ruysschaert, J. M. Cationic liposomal lipids: From gene carriers to cell signaling. Prog. Lipid Res. 2008, 47 (5), 340-347
17. Nwariaku, F. E.; Chang, J.; Zhu, X.; Liu, Z.; Duffy, S. L.; Halaihel, N. H.; Terada, L.; Turnage, R. H. The role of p38 map kinase in tumor necrosis factor-induced redistribution of vascular endothelial cadherin and increased endothelial permeability. Shock 2002, 18 (1), 82-85
18. Campbell, R. B.; Fukumura, D.; Brown, E. B.; Mazzola, L. M.; Izumi, Y.; Jain, R. K.; Torchilin, V. P.; Munn, L. L. Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. Cancer Res. 2002, 62 (23), 6831-6836.
19. Schmitt-Sody, M.; Strieth, S.; Krasnici, S.; Sauer, B.; Schulze, B.; Teifel, M.; Michaelis, U.; Naujoks, K.; Dellian, M. Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy. Clin. Cancer Res. 2003, 9 (6), 2335-2341 (Pubitemid 36687660)
20. Strieth, S.; Eichhorn, M. E.; Sauer, B.; Schulze, B.; Teifel, M.; Michaelis, U.; Dellian, M. Neovascular targeting chemotherapy: encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature. Int. J. Cancer 2004, 110 (1), 117-124 (Pubitemid 38507211)
21. Kalra, A. V.; Campbell, R. B. Development of 5-FU and doxorubicin-loaded cationic liposomes against human pancreatic cancer: Implications for tumor vascular targeting. Pharm. Res. 2006, 23 (12), 2809-2817
22. Wu, J.; Lee, A.; Lu, Y.; Lee, R. J. Vascular targeting of doxorubicin using cationic liposomes. Int. J. Pharm. 2007, 337 (1-2), 329-335
23. Eichhorn, M. E.; Luedemann, S.; Strieth, S.; Papyan, A.; Ruhstorfer, H.; Haas, H.; Michaelis, U.; Sauer, B.; Teifel, M.; Enders, G.; Brix, G.; Jauch, K. W.; Bruns, C. J.; Dellian, M. Cationic Lipid Complexed Camptothecin (EndoTAG®-2) Improves Antitumoral Efficacy by Tumor Vascular Targeting. Cancer Biol. Ther. 2007, 6, 6.
24. Campbell, R. B.; Ying, B.; Kuesters, G. M.; Hemphill, R. Fighting cancer: From the bench to bedside using second generation cationic liposomal therapeutics. J. Pharm. Sci. 2009, 98 (2), 411-429
25. Dass, C. R. Improving anti-angiogenic therapy via selective delivery of cationic liposomes to tumour vasculature. Int. J. Pharm. 2003, 267 (1-2), 1-12.
26. Dass, C. R.; Choong, P. F. Cancer angiogenesis: targeting the heel of Achilles. J. Drug Targeting 2008, 16 (6), 449-454 (Pubitemid 352015813)
27. Michaelis, U.; Haas, H. Targeting of Cationic Liposomes to Endothelial Tissue. In Liposome Technology, Volume III: Interactions of Liposomes with the Biological Milieu, 3rd ed.; Gregoriadis, G., Ed.; Taylor and Francis: New York, 2006.
28. Kirk, S. L.; Karlik, S. J. VEGF and vascular changes in chronic neuroinflammation. J Autoimmun. 2003, 21 (4), 353-363
29. Kirk, S.; Frank, J. A.; Karlik, S. Angiogenesis in multiple sclerosis: is it good, bad or an epiphenomenon? J. Neurol. Sci. 2004, 217 (2), 125-130 (Pubitemid 38056544)
30. Wekerle, H.; Kojima, K.; Lannes-Vieira, J.; Lassmann, H.; Linington, C. Animal models. Ann. Neurol. 1994, 36, S47-53.
31. Gold, R.; Linington, C.; Lassmann, H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006, 129 (Part 8), 1953-1971 (Pubitemid 44289062)
32. Augustin, H. G.; Braun, K.; Telemenakis, I.; Modlich, U.; Kuhn, W. Ovarian angiogenesis - phenotypic characterization of endothelial- cells in a physiological model of blood-vessel growth and regression. Am. J. Pathol. 1995, 147 (2), 339-351
33. New, R. R. C. Liposomes - A practical approach; IRL Press: Cary, NC, 1990.
34. Deibler, G. E.; Burlin, T. V.; Stone, A. L. Three isoforms of human myelin basic protein: purification and structure. J. Neurosci. Res. 1995, 41 (6), 819-827
35. Cavaletti, G.; Cavalletti, E.; Crippa, L.; Di Luccio, E.; Oggioni, N.; Mazzanti, B.; Biagioli, T.; Sala, F.; Sala, V.; Frigo, M.; Rota, S.; Tagliabue, E.; Stanzani, L.; Galbiati, S.; Rigolio, R.; Zoia, C.; Tredici, G.; Perseghin, P.; Dassi, M.; Riccio, P.; Lolli, F. Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis. J. Neuroimmunol. 2004, 151 (1-2), 55-65.
36. Mazzanti, B.; Biagioli, T.; Aldinucci, A.; Cavaletti, G.; Cavalletti, E.; Oggioni, N.; Frigo, M.; Rota, S.; Tagliabue, E.; Ballerini, C.; Massacesi, L.; Riccio, P.; Lolli, F. Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis. J. Neuroimmunol. 2005, 168 (1-2), 111-117 (Pubitemid 41396408)
37. McLean, J. W.; Fox, E. A.; Baluk, P.; Bolton, P. B.; Haskell, A.; Pearlman, R.; Thurston, G.; Umemoto, E. Y.; McDonald, D. M. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am. J. Physiol. 1997, 273 (1 Part 2), H387-404.
38. Rousseau, V.; Denizot, B.; Le Jeune, J. J.; Jallet, P. Early detection of liposome brain localization in rat experimental allergic encephalomyelitis. Exp. Brain Res. 1999, 125 (3), 255-264 (Pubitemid 29134811)
39. Rausch, M.; Hiestand, P.; Baumann, D.; Cannet, C.; Rudin, M. MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE. Magn. Reson. Med. 2003, 50 (2), 309-314 (Pubitemid 36950850)
40. Floris, S.; Blezer, E. L.; Schreibelt, G.; Dopp, E.; van der Pol, S. M.; Schadee-Eestermans, I. L.; Nicolay, K.; Dijkstra, C. D.; de Vries, H. E. Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain 2004, 127 (Pt 3), 616-627
41. Manninger, S. P.; Muldoon, L. L.; Nesbit, G.; Murillo, T.; Jacobs, P. M.; Neuwelt, E. A. An exploratory study of ferumoxtran-10 nanoparticles as a blood-brain barrier imaging agent targeting phagocytic cells in CNS inflammatory lesions. AJNR Am. J. Neuroradiol. 2005, 26 (9), 2290-2300
42. Cavaletti, G. Current status and future prospective of immuno-intervention in multiple sclerosis. Curr. Med. Chem. 2006, 13 (19), 2329-2343 (Pubitemid 44184656)
43. Calvo, P.; Gouritin, B.; Villarroya, H.; Eclancher, F.; Giannavola, C.; Klein, C.; Andreux, J. P.; Couvreur, P. Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat. Eur. J. Neurosci. 2002, 15 (8), 1317-1326.
44. Schmidt, J.; Metselaar, J. M.; Wauben, M. H.; Toyka, K. V.; Storm, G.; Gold, R. Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis. Brain 2003, 126 (Part 8), 1895-1904 (Pubitemid 36917348)
45. Filion, M. C.; Phillips, N. C. Anti-inflammatory activity of cationic lipids. Br. J. Pharmacol. 1997, 122 (3), 551-557